These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1714392)

  • 1. Comparative studies of decay-accelerating factor and HLA-DR within the CD8-brightly positive population.
    Tomita A; Okada N; Okada H
    Eur J Immunol; 1991 Aug; 21(8):1843-8. PubMed ID: 1714392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF).
    Nicholson-Weller A; Russian DA; Austen KF
    J Immunol; 1986 Aug; 137(4):1275-9. PubMed ID: 3090145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.
    Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K
    Cancer Res; 1992 Feb; 52(4):775-81. PubMed ID: 1737336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy.
    Saito S; Nishikawa K; Morii T; Narita N; Enomoto M; Ichijo M
    Immunology; 1992 Apr; 75(4):710-2. PubMed ID: 1592443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis.
    Iannone F; Corrigall VM; Kingsley GH; Panayi GS
    Eur J Immunol; 1994 Nov; 24(11):2706-13. PubMed ID: 7957563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N; Sanjoh K; Yokoyama S; Hayashi T
    J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
    Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
    Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine thymic nurse cell clone supports the growth of fetal thymocytes in the presence of interleukin 2.
    Doi H; Nakagawa S; Nagata K; Hata M; Kasahara S; Sakata T; Suzuki R; Nanno M; Sugamura K; Itoh T
    Eur J Immunol; 1991 Mar; 21(3):783-92. PubMed ID: 1672648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
    Mold C; Walter EI; Medof ME
    J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes.
    Kammer GM; Walter EI; Medof ME
    J Immunol; 1988 Nov; 141(9):2924-8. PubMed ID: 2459233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.